Cellebrite concluded 2025 with a robust fourth quarter, marked by a 21% increase in total ARR to $480.8 million and an 18% rise in revenue to $128.8 million. The company achieved a net income of $21.3 million and an adjusted EBITDA of $38.3 million, reflecting strong operational performance and strategic progress, despite a challenging U.S. Federal spending environment.
Total ARR grew 21% year-over-year to $480.8 million, with organic ARR growth of 17% excluding Corellium.
Revenue increased by 18% year-over-year to $128.8 million, driven by strong subscription revenue growth of 21%.
Net income for the quarter was $21.3 million, supporting a non-GAAP net income of $36.7 million.
Adjusted EBITDA reached $38.3 million, representing a 29.8% adjusted EBITDA margin.
Cellebrite anticipates continued accelerated ARR growth and strong operating profitability in 2026, driven by strategic initiatives and market tailwinds, despite potential FX impacts.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance